BrightOwl Loader Loading


Broad experience as Chief Executive Officer, Finance & Administrative Director and Business Consultant in various sectors and especially in fast growing and changing environments. Profound and practical business knowledge (25 years in finance, corporate finance, HRM, tax & legal, investor relations, business development and operations), critical in thinking, thorough, with strong commitment, good people management skills and hands-on. Summary of my professional achievements : • Realized growth (revenues & personnel) of a local start-up company towards a global listed Group; • Realized value creation (e.g. from local academic research to clinical development in Europe & US); • Closed strategic corporate partnership transactions & managed several acquisitions; • Closed significant financing rounds (IPO, private placements and grants) despite tough (market) conditions; • Designed and lead corporate transition/change processes; • Realized severe cost reduction while optimizing allocation of limited resources; • Implemented good corporate governance practices; • Improved business insight and facilitated fact-based operational & strategic decision making.


Current Experience

  • Director / CEO / CFO for innovative companies
    Since January 2011
    Advising innovative fast growing/changing companies on key strategic, corporate finance and financial matters. Director of S.I.S.E. sa - Platform for Cell Therapy.

Past Experience

  • CEO & CFO
    January 2006 --- January 2010
    Chief Executive Officer (2008-2010) Chief Financial Officer (2006-2007) ACCOMPLISHMENTS AND RESULTS ACHIEVED • Moved two pre-clinical anti-cancer drug candidates to clinical Phase I, one in the US (IND-FDA) & one in Europe (IMPD-EMEA); • Closed strategic alliance for late preclinical compound worth $ 31M with US based pharmaceutical company; • Closed several financing rounds (raised € 8M - private placements and grants) for early-stage pipeline; • Realized severe cost reduction (Net Result + 45%) while optimizing allocation of resources and starting 2 clinical trials. Duties and responsibilities • Lead the transition from a university spin-off towards a professional biotech company with limited resources; • Made analysis & strategic plan for cancer drug development and discovery activities; defined & managed priorities in line with pharma industry, oncology experts’ and investors’ expectations (value creation); strictly coordinated & monitored progress in development (milestones); • Negotiated & coordinated all M&A and financing transactions, incl. due diligence work; • Implemented good corporate governance practices; • Reported transparent information to BOD and private & public stakeholders, and managed expectations.

  • Sarbanes-Oxley & Compliance Officer
    January 2004 --- January 2006
    . ACCOMPLISHMENTS AND RESULTS ACHIEVED • Improved Compliance of all subsidiaries worldwide with internal (ING Group) and external laws and regulations, including Sarbanes-Oxley, Operational & Information Risk Management, Financial Economic Crime, …

  • Head of Finance Division
    January 2001 --- January 2003
    . ACCOMPLISHMENTS AND RESULTS ACHIEVED • Designed and lead change process from local statutory accounting towards a professional finance department with pro-active & international management reporting per business segment and including a treasury department; • Re-defined business processes and streamlined policies & analytical structure according to international guidelines to prepare E&Y Belgium for E&Y International Global Profit Sharing; • Presented results to the local Executive Committee and to E&Y International.

  • Group Finance & Admin. Director
    January 1997 --- January 2001
    . ACCOMPLISHMENTS AND RESULTS ACHIEVED • Managed administrative & financial growth (revenues & personnel) of a start-up IT Company towards a global listed Group, through several critical stages : • All financing rounds since incorporation (raised > $ 135M); • Six acquisitions (both in the US & in Europe); • IPO of a global high tech software security Company on the EASDAQ stock exchange - carried out successfully in June 2000 despite crash of Tech markets. Preparation of information for the beauty contest to select the lead bank (ING, London); due diligence; prospectus writing, business plan & business strategy definition; new reporting & communication rules of a public company; Investor Relations; • Managed all administrative/legal/HRM activities; responsible for financial analyses, treasury, due diligence exercises related to M&A and financing transactions, business plans, valuations, group-wide management reporting system (USGAAP) and policies & procedures; • Managed integration work to align the acquired companies, to enable tracking & analyzing of KPI’s in the various business units and to make the Group benefit from synergies (to boost revenues and to cut costs).

  • Financial Controller
    January 1991 --- January 1996
    • Prepared consolidated Group management information & detailed audit reports (profitability studies, audit of current account of managers/founders, analyses & re-negotiation of bank debts & related guarantees, forecasts, business plan) for the BOD, the Audit Committee and the Shareholders to enable the BOD to take appropriate business decisions; • Analyzed profitability of projects, subsidiary performance & acquisition targets and the effect on profitability of different scenarios to restructure the business; recommended & implemented cost saving measures & improvements (optimized fiscal structure, re-organized & reduced number of offices in Belgium, closed down the office in the US, …); analyzed the return on investments for projects; recommended which investments were preferably to be sold (MBO of construction company), which activities to be terminated (project development) & where to focus commercial activities; • Developed recommendations and implemented decisions taken to restructure the business; • (Re)-negotiated bank loans & credit facilities, designed & implemented cash pooling; • Developed and analyzed business plans for/from new investors/business partners; • Secretary to the BOD.

  • Senior Auditor
    January 1986 --- January 1991
    Conducted audits in various sectors (Energy suppliers, Airports, Food companies, Chemical companies, Insurance companies & Banks) and advised clients on financial statements and financial reporting.

  • Finance Department Assistant for 5 consecutive summers
    January 1981 --- January 1985


LinkedIn Assessment :
Corporate FinanceDue DiligenceBusiness StrategyChange ManagementMergersStart-upsVenture CapitalFinancial AnalysisMergers & AcquisitionsStrategyRestructuringmanagementValuationRisk ManagementFinanceForecastingBusiness DevelopmentBusiness Planning


  • Masters in Applied Economics from U.F.S.I.A. (University of Antwerp) in 1986

Area / Region

Schelle, Belgium


Driving License
  • Yes